EUVIMEDEUVIMED entdecken
Crossref

Positive Strongyloides Serology: A Descriptive Analysis Across Geographically Distinct Academic Medical Centers

Sandhya R Nagarakanti iD, Jamilah L Shubeilat, Ali Abdulsahib, Natasha P Dyal, Matt Biondi, Joseph Hentz, Erin Kaleta, Holenarasipur R Vikram iD

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Sandhya R Nagarakanti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Strongyloidiasis, Strongyloides stercoralis, Antibodies, Helminth, Organ Transplantation. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Strongyloides stercoralis is an intestinal parasitic nematode that can infect humans with a 2%–7% prevalence in the United States. Immunosuppression is a crucial risk factor for disseminated infection. Diagnosis is often delayed and targeted treatment is frequently initiated late. We therefore sought to review the prevalence of positive Strongyloides antibody results and undertook a descriptive analysis of such patients.

Methods

We retrospectively reviewed patients with positive Strongyloides IgG serology from August 2012 to April 2023 across geographically distinct academic medical centers. Study period pre‐dated universal donor and recipient Strongyloides screening recommendation by the Organ Procurement and transplantation network (OPTN). Clinical presentation was classified into three categories: chronic infection (positive Strongyloides IgG serology without additional clinical manifestations), hyperinfection syndrome (positive serology with involvement of the skin, gastrointestinal tract, or lungs), and disseminated infection (positive serology with involvement beyond those typically involved in hyperinfection).

Results

A total of 412 patients were identified; median age was 59 years and 66% (272) were male. The primary indication for testing was pretransplant evaluation in 230 (56%), eosinophilia workup in 84 (20%), suspicion of symptomatic infection in 74 (18%), testing based on travel history in 27 (7%), and pre‐immunosuppression screening in 27 (7%). Furthermore, 401 patients (97.3%) were categorized as having chronic infection, 10 patients (2.42%) had hyperinfection, and one patient (0.24%) had disseminated infection, presenting with Escherichia coli bacteremia and meningitis. Symptomatic infection was more common at the Mayo Clinic in Rochester and Mayo Clinic Health Sciences than at the Arizona and Florida Mayo Clinic sites (6% vs. 2%, p = 0.079). Treatment was administered to 366/412 (89%) patients.

Conclusion

Most patients with positive Strongyloides serology were asymptomatic, and treatment regimens were not uniform. Patients who tested positive should be treated prior to immunosuppression initiation, though this was not systematically assessed in this cohort. The observed variability in treatment regimens highlights the need for standardized protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrongyloidiasisStrongyloides stercoralisAntibodies, HelminthOrgan TransplantationHumansMaleAnimalsFemaleRetrospective StudiesAcademic Medical CentersMiddle AgedUnited StatesAdultAgedImmunoglobulin GPrevalence

Stichwörter der Autor:innen

Strongyloides screeningtransplanttreatment

Substanzen

Antibodies, HelminthImmunoglobulin G

Autor:innen und Institutionen

  • Division of Infectious Disease, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Research and Biostatistics, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.
  • Division of Infectious Diseases and Transplant Center, Mayo Clinic, Phoenix, Arizona, USA.

ORCID-Profile: Sandhya R Nagarakanti, Holenarasipur R Vikram

Zitieren

APA

Nagarakanti, S. R., Shubeilat, J. L., Abdulsahib, A., Dyal, N. P., Biondi, M., Hentz, J., Kaleta, E., & Vikram, H. R. (2026). Positive Strongyloides Serology: A Descriptive Analysis Across Geographically Distinct Academic Medical Centers. Transplant Infectious Disease. https://doi.org/10.1111/tid.70276

Vancouver

Nagarakanti SR, Shubeilat JL, Abdulsahib A, Dyal NP, Biondi M, Hentz J, et al. Positive Strongyloides Serology: A Descriptive Analysis Across Geographically Distinct Academic Medical Centers. Transplant Infectious Disease. 2026. doi:10.1111/tid.70276

BibTeX
@article{Nagarakanti2026,
  author = {Nagarakanti, Sandhya R and Shubeilat, Jamilah L and Abdulsahib, Ali and Dyal, Natasha P and Biondi, Matt and Hentz, Joseph and Kaleta, Erin and Vikram, Holenarasipur R},
  title = {Positive Strongyloides Serology: A Descriptive Analysis Across Geographically Distinct Academic Medical Centers},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70276}
}
Kostenlos starten →